# Pilot Study of Safety and Efficacy of Spheramine

> **NCT00761436** · PHASE2 · TERMINATED · sponsor: **Bayer** · enrollment: 6 (actual)

## Conditions studied

- Parkinson''s Disease

## Interventions

- **BIOLOGICAL:** Spheramine (BAY86-5280)

## Key facts

- **NCT ID:** NCT00761436
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-02-29
- **Primary completion:** 2012-05-14
- **Final completion:** 2012-05-14
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Study was completed, only life long extended follow-up phase was discontinued after 12 years
- **Last updated:** 2021-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00761436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00761436, "Pilot Study of Safety and Efficacy of Spheramine". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00761436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*